18536580

Source:http://linkedlifedata.com/resource/pubmed/id/18536580

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001675, umls-concept:C0023449, umls-concept:C0087111, umls-concept:C1280477
pubmed:issue	4
pubmed:dateCreated	2008-6-9
pubmed:abstractText	Despite improvements in the achievement of complete remission and progress in the supportive care of adults with acute lymphoblastic leukemia during the last decade, the majority of patients have eventually relapsed with overall survival in adult acute lymphoblastic leukemia of only 30-40%. However, the recent approach of adapting therapy according to biologic features appears to be resulting in significant progress for specific subsets of adults with acute lymphoblastic leukemia.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9430802
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1531-7048
pubmed:author	pubmed-author:LarsonSarahS, pubmed-author:StockWendyW
pubmed:issnType	Electronic
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	400-7
pubmed:meshHeading	pubmed-meshheading:18536580-Age Factors, pubmed-meshheading:18536580-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:18536580-Humans, pubmed-meshheading:18536580-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:18536580-Survival Rate
pubmed:year	2008
pubmed:articleTitle	Progress in the treatment of adults with acute lymphoblastic leukemia.
pubmed:affiliation	University of Chicago Medical Center and the University of Chicago Cancer Research Center, University of Chicago, Chicago, Illinois, USA.
pubmed:publicationType	Journal Article, Review